organohalogen compound ether fluvoxamine PMID:32672818 DrugBank:DB00176 PMID:18976545 318.340 PMID:16316311 2-{[(E)-{5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethan-1-amine 318.15551 PDBeChem:FVX PMID:31807102 PMID:29379174 PMID:7988100 Patent:NL7503310 KEGG:C07571 CHEBI:5138 PMID:11825104 0 Drug_Central:1230 C15H21F3N2O2 PMID:24121440 KEGG:D07984 PMID:20573265 fluvoxamine PMID:32618683 (1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime PMID:31807753 InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+ HMDB:HMDB0014322 PMID:9164424 fluvoxamina PMID:22859721 Patent:US4085225 An oxime O-ether that is benzene substituted by a (1E)-N-(2-aminoethoxy)-5-methoxypentanimidoyl group at position 1 and a trifluoromethyl group at position 4. It is a selective serotonin reuptake inhibitor that is used for the treatment of obsessive-compulsive disorder. PMID:10456487 PMID:30690950 MetaCyc:CPD-20520 PMID:20025739 PMID:33180097 CJOFXWAVKWHTFT-XSFVSMFZSA-N Fluvoxamine PMID:15686112 chebi_ontology PMID:30734885 COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F PMID:33392622 Chemspider:4481878 Wikipedia:Fluvoxamine Beilstein:5583954 fluvoxaminum O-(2-aminoethyl)-N-{(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}hydroxylamine CAS:54739-18-3 PMID:12107854